Press Releases

Seattle, WA - Mar 11, 2014

Thomas L. Skillman Joins BRI as the First Director of Research Technology

Benaroya Research Institute at Virginia Mason (BRI) recently named Thomas L. Skillman as BRI’s first Director of Research Technology. Skillman will collaborate with research staff on novel research programs with a technology emphasis including the design and management of the scientific computing infrastructure. This infrastructure will assist researchers in the management, analysis and sharing of their scientific data.

Skillman’s experience includes more than 20 years in research and development management including working with health science organizations, providing both strategic planning and operational leadership. He was previously a principal of Epigenomics and the first Senior Deputy Director of the HIV Statistical Center at Fred Hutchinson Cancer Research Center. He also provided business and information system leadership to two University of Washington start-up companies, Seattle Sensor Systems and Cardiac Mimetics, and maintains close connections to the UW eScience Institute. Skillman received an Executive MBA from the University of Washington as well as an MS in Computer Science and a BS in Physics, both from the University of Maryland.

“As our BRI scientists work to understand the function and dysfunction of the human immune system,” notes Skillman, “they increasingly rely on a growing volume of research data. Having the technology in place to measure, store, integrate and analyze this data is key to increasing the impact of their research.”

Featured BRI Building Exterior 2024

About Benaroya Research Institute

Benaroya Research Institute (BRI) is a world leader in human immune system research. BRI works to advance the science that will predict, prevent, reverse and cure immune system diseases like allergies, asthma, cancer and autoimmune diseases. BRI accelerates discovery through laboratory breakthroughs in immunology that are then translated to clinical therapies. We believe that a breakthrough in one immune system disease can lead to progress against them all, and work tirelessly toward our vision of a healthy immune system for everyone. BRI is a world-renowned independent nonprofit research institute affiliated with Virginia Mason Franciscan Health and based in Seattle.

To learn more, visit benaroyaresearch.org and connect with us on Facebook, Instagram, Threads, LinkedIn, X and YouTube.